Evidence map›Paper›PMID 19546173›Full record

ArticleCardiovascular research2009

Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism.

Denis J Glenn, Dolkun Rahmutula, Minobu Nishimoto, Faquan Liang, David G Gardner

Abstract read
In one paragraph

Article in Cardiovascular research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Serine 105 phosphorylation of transcription factor GATA4 is necessary for stress-induced cardiac hypertrophy in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  16. Article
  17. Review
  18. Endothelin-1 gene regulation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2011
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Denis J GlennDepartment of Medicine, University of California at San Francisco, San Francisco, CA, USA.
Dolkun Rahmutula
Minobu Nishimoto
Faquan Liang
David G Gardner

Funding

REGULATION OF ANP RECEPTOR ACTIVITY IN VASCULAR CELLSR01HL045637 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GARDNER, DAVID G · 1992 to 2011
$3.6M
Characterization of the Vitamin D System in Normal and Hypertrophied HeartF32HL086158 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GLENN, DENIS J · 2006 to 2008
$110k
NHLBI NIH HHS F32 HL086158NHLBI NIH HHS HL45637NHLBI NIH HHS HL86158NHLBI NIH HHS R01 HL045637
6 · The paper itself

Abstract

aimsAtrial natriuretic peptide (ANP) is a hormone that has both antihypertrophic and antifibrotic properties in the heart. We hypothesized that myocyte-derived ANP inhibits endothelin (ET) gene expression in fibroblasts. METHODS AND

resultsWe have investigated the mechanism(s) involved in the antiproliferative effect of ANP on cardiac fibroblasts in a cell culture model. We found that cardiac myocytes inhibited DNA synthesis in co-cultured cardiac fibroblasts as did treatment with the ET-1 antagonist BQ610. The effect of co-culture was reversed by antibody directed against ANP or the ANP receptor antagonist HS-142-1. ANP inhibited the expression of the ET-1 gene and ET-1 gene promoter activity in cultured fibroblasts. The site of the inhibition was localized to a GATA-binding site positioned between -132 and -135 upstream from the transcription start site. GATA4 expression was demonstrated in cardiac fibroblasts, GATA4 bound the ET-1 promoter both in vitro and in vivo, and siRNA-mediated knockdown of GATA4 inhibited ET-1 expression. ET-1 treatment resulted in increased levels of phospho-serine(105) GATA4 in cardiac fibroblasts and this induction was partially suppressed by co-treatment with ANP.

conclusionCollectively, these findings suggest that locally produced ET-1 serves as an autocrine stimulator of fibroblast proliferation, that ANP produced in neighbouring myocytes serves as a paracrine inhibitor of this proliferation, and that the latter effect operates through a reduction in GATA4 phosphorylation and coincident reduction in GATA4-dependent transcriptional activity.

Indexed as

Cell ProliferationAnimalsAnimals, NewbornAtrial Natriuretic FactorAutocrine CommunicationBinding SitesCells, CulturedCoculture TechniquesDNA ReplicationDose-Response Relationship, DrugDown-RegulationEndothelin-1Extracellular Signal-Regulated MAP KinasesFibroblastsGATA4 Transcription FactorHeart VentriclesAtrial Natriuretic FactorBQ 610Endothelin-1Extracellular Signal-Regulated MAP KinasesGata4 protein, ratGATA4 Transcription FactorHS 142-1OligopeptidesPolysaccharidesReceptors, Atrial Natriuretic FactorSerine

Identifiers

PMID19546173
PMCPMC2761198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.